Last reviewed · How we verify
Candidiasis of mouth
Approved treatments
- Lotrimin · Bayer AG
- Abelcet · Astellas Pharma
- Mycostatin · Generic (originally Squibb)
- Diflucan · Pfizer Inc.
- Fluconazol · Azienda Sanitaria-Universitaria Integrata di Udine
- Monistat · Johnson & Johnson (Janssen)
- Nizoral · Johnson & Johnson (Janssen)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Candidiasis of mouth patent landscape — cliff calendar, originator estates, attackable patents
- Candidiasis of mouth treatment landscape brief
- Candidiasis of mouth treatment updates RSS
Frequently asked questions about Candidiasis of mouth
What drugs treat Candidiasis of mouth?
Tracked treatments include Lotrimin, Abelcet, Mycostatin, Diflucan, Fluconazol, Monistat, Nizoral.
What is the treatment for Candidiasis of mouth?
Standard treatment for Candidiasis of mouth includes Lotrimin, Abelcet, Mycostatin, Diflucan, Fluconazol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Candidiasis of mouth patent cliff · Candidiasis of mouth CI report
- Treatment: Lotrimin · Bayer AG
- Treatment: Abelcet · Astellas Pharma
- Treatment: Mycostatin · Generic (originally Squibb)
- Treatment: Diflucan · Pfizer Inc.
- Treatment: Fluconazol · Azienda Sanitaria-Universitaria Integrata di Udine
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing